Evidence map›Paper›PMID 40961086›Full record

ArticlePloS one2025

Green synthesis, characterization, molecular simulation, and in vitro biomedical application of magnesium oxide nanoparticles.

Samy Selim, Mohamed K Y Soliman, Mohammed S Almuhayawi, Mohammed H Alruhaili, Hattan S Gattan, Amna A Saddiq, Nashwa Hagagy, Ashwag Jaman Alzahrani, Soad K Al Jaouni, Salem S Salem

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID 0000-0003-4025-8586
Mohamed K Y SolimanBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.
Mohammed S AlmuhayawiDepartment of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammed H AlruhailiDepartment of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Hattan S GattanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Amna A SaddiqDepartment of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia.
Nashwa HagagyDepartment of Biology, College of Science & Arts at Khulis, University of Jeddah, Jeddah, Saudi Arabia.
Ashwag Jaman AlzahraniDepartment of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia.
Soad K Al JaouniDepartment of Hematology/Oncology, Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University and Hospital, Jeddah, Saudi Arabia.
Salem S SalemBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.ORCID 0000-0003-2898-6708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial infections represent a major hazard to global public health, resulting in extensive morbidity and mortality across the globe. As a result, in the past 10 years, nanoparticles have drawn a lot of interest in their potential to manage microbial diseases. One of the few studies that has used a green and environmentally acceptable approach of producing magnesium oxide nanoparticles (MgONPs) was employed via using an extract from watermelon peels. UV-visible, FTIR, XRD, and TEM were used to comprehensively characterize the biosynthesized MgONPs. The synthetic MgONPs have a polycrystalline form with a median particle size of 6-17 nm, according on the characterization of the material. According to the antimicrobial results, MgONPs showed notable antimicrobial properties toward B. subtitles, S. aureus, E. coli, P. aeruginosa, and C. albicans, with an inhibition zone measuring 18.2 ± 0.36, 23.7 ± 0.4, 15.4 ± 0.25, 17.6 ± 0.56, and 16.3 ± 0.32 mm respectively. While the minimum inhibitory concentrations (MICs) varied from 50 to 200 µg/mL. MgONPs have successfully demonstrated antibiofilm potential versus MRSA. A molecular docking simulation was carried out to obtain a better understanding of the potential mechanism of MgO-NPs against the S. aureus strain. The results imply that the activity may be attributed to the dihydrofolate reductase (DHFR) with a varying degree, and the predominant interaction observed is the hydrophobic interaction with the residues' amino acids in the active site of the pocket in S. aureus. Furthermore, the DPPH technique revealed that MgONPs had considerable antioxidant activity, with an IC50 of 223 µg/mL. Additionally, at a dosage of 62.5 µg/mL, MgONPs exhibit possible antiviral efficacy against HAV and HSV1, with proportions of 84.7 and 49.7%, respectively. Finally, the watermelon peel extract biosynthesized MgONPs exhibit antimicrobial, antibiofilm, antioxidant, and antiviral properties that show promise to be utilized in the biomedical field.

Indexed as

Anti-Infective AgentsMagnesium OxideMetal NanoparticlesNanoparticlesAntioxidantsCandida albicansCitrullusGreen Chemistry TechnologyMicrobial Sensitivity TestsMolecular Docking SimulationPlant ExtractsStaphylococcus aureusTetrahydrofolate DehydrogenaseAnti-Infective AgentsAntioxidantsMagnesium OxidePlant ExtractsTetrahydrofolate Dehydrogenase

Identifiers

PMID40961086
PMCPMC12443314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.